Nasal Vaccines Market Expected To Reach US$ 416.8 Million By 2023

https://www.coherentmarketinsights.com/market-insight/nasal-vaccines-market-5818
Nasal Vaccines Market

Market Overview:

Nasal vaccines are a type of immunization administered through the nasal route. They offer numerous advantages such as ease of administration, painless delivery, and stimulation of both systemic and mucosal immune responses. The need for nasal vaccines is associated with the increasing prevalence of infectious diseases and the growing demand for needle-free immunization methods. Nasal vaccines have been proven effective against various diseases such as influenza, measles, and polio. The market for nasal vaccines is expected to witness significant growth due to their ability to provide long-lasting immunity and reduce the risk of disease transmission.

Market Key Trends:

One key trend in the Nasal vaccine market is the rising adoption of intranasal delivery systems. Nasal vaccines provide several benefits compared to traditional injectable vaccines, such as improved patient compliance, reduced pain and fear associated with injections, and the potential to elicit a stronger immune response. Intranasal delivery systems also enable the delivery of vaccines directly to the mucosal surfaces of the respiratory tract, where many infectious pathogens enter the body.

The global Nasal Vaccines Market Demand is estimated to be valued at US$416.8 million in 2023 and is expected to exhibit a CAGR of 8.6% over the forecast period 2023-2030, according to a new report published by Coherent Market Insights.


Segment Analysis:

The nasal vaccines market can be segmented based on type, application, and end-user. Based on type, the market can be divided into inactivated vaccines, live attenuated vaccines, and subunit vaccines. Among these, live attenuated vaccines dominate the market due to their ability to mimic natural infection and provide long-lasting immunity. These vaccines contain weakened or modified forms of the pathogen and have been proven effective against various diseases such as influenza and measles. Due to their higher efficacy, live attenuated vaccines are preferred over other types.

Key Takeaways:

The global nasal vaccines market is expected to witness high growth, exhibiting a CAGR of 8.6% over the forecast period. This growth can be attributed to several factors, including the increasing prevalence of infectious diseases, rising awareness about vaccination, and advancements in vaccine technology. The market is expected to reach US$ 416.8 million in 2023.

In terms of regional analysis, North America is the fastest-growing and dominating region in the nasal vaccines market. This can be attributed to the presence of key market players, well-established healthcare infrastructure, and high healthcare expenditure in the region. Additionally, the increasing incidence of respiratory diseases and the growing demand for preventive healthcare are driving the market growth in North America.

Key players operating in the nasal vaccines market include AstraZeneca, GlaxoSmithKline plc, Pfizer Inc., Serum Institute of India Pvt. Ltd., Sanofi Pasteur SA, Johnson & Johnson Services, Inc., Sinovac Biotech Ltd., Bharat Biotech International Limited, Altimmune, Inc., BiondVax Pharmaceuticals Ltd., FluGen Inc., Vaxart, Inc., Intravacc, Ennaid Therapeutics, LLC, and Gamma Vaccines Pty Ltd. These key players are focusing on strategic partnerships, mergers and acquisitions, and product launches to strengthen their market presence and expand their product portfolio.

Read More: https://www.newsstatix.com/nasal-vaccines-market-growing-demand-for-non-invasive-vaccination-drives-market-growth/

Comments

Popular posts from this blog

Agricultural Micronutrients Market Growth Accelerated By Increasing Need For Improved Soil Fertility

Dairy Alternative Market Expected To Reach USD 26.01 Billion By 2023

Antimicrobial Additives Market Growth Accelerated By Rising Demand From End-Use Industries